baltimore conference logo
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Thor Halfdanarson, MD | Authors

Articles

Determining Treatment Options for Select Subsets of Neuroendocrine Tumors

November 02, 2018

Video

Thor Halfdanarson, MD, discusses his takeaway message on neuroendocrine tumors (NETs) at the 2018 ISGIO Annual Conference.